Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Jazz Pharmaceuticals plc market cap is $6.82B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Jazz Pharmaceuticals plc 52 week high is $146.70 as of April 27, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Jazz Pharmaceuticals plc 52 week low is $106.61 as of April 27, 2024.
Jazz Pharmaceuticals plc stock price today is $109.46.
Jazz Pharmaceuticals plc stock price yesterday was $107.43.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Jazz Pharmaceuticals plc’s P/E ratio is 18.96.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Jazz Pharmaceuticals plc P/B ratio is 1.8235.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Jazz Pharmaceuticals plc's EBITDA is 9.81.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Jazz Pharmaceuticals plc 50-day moving average is $118.38.
Jazz Pharmaceuticals plc has 2,800 employees.